首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and evaluation of α-ketotriazoles and α,β- diketotriazoles as inhibitors of Mycobacterium tuberculosis
【24h】

Synthesis and evaluation of α-ketotriazoles and α,β- diketotriazoles as inhibitors of Mycobacterium tuberculosis

机译:结核分枝杆菌抑制剂α-酮三唑和α,β-二酮三唑的合成与评价

获取原文
获取原文并翻译 | 示例
           

摘要

Two series of α-ketotriazole and α,β-diketotriazole derivatives were synthesized and evaluated for antitubercular and cytotoxic activities. Among them, two α,β-diketotriazole compounds, 6b and 9b, exhibited good activities (minimum inhibitory concentration = 7.6 μM and 6.9 μM, respectively) on Mycobacterium tuberculosis and multi-drug resistant M. tuberculosis strains and presented no cytotoxicity (IC50 50 μM) on colorectal cancer HCT116 and normal fibroblast GM637H cell lines. These two compounds represent promising leads for further optimization.
机译:合成了两个系列的α-酮三唑和α,β-二酮三唑衍生物,并评估了其抗结核和细胞毒性活性。其中,两种α,β-二酮三唑化合物6b和9b对结核分枝杆菌和耐多药结核分枝杆菌菌株表现出良好的活性(最低抑菌浓度分别为7.6μM和6.9μM),并且没有细胞毒性(IC50> 50μM)对结直肠癌HCT116和正常成纤维细胞GM637H细胞系的影响。这两种化合物代表了进一步优化的前景广阔的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号